<?xml version="1.0" encoding="UTF-8"?>
<p>Co‐infection and co‐occurrence of Covid‐19 and dengue have introduced a significant burden on healthcare systems in dengue‐endemic regions.
 <xref rid="rmv2161-bib-0035" ref-type="ref">
  <sup>35</sup>
 </xref>, 
 <xref rid="rmv2161-bib-0036" ref-type="ref">
  <sup>36</sup>
 </xref>, 
 <xref rid="rmv2161-bib-0037" ref-type="ref">
  <sup>37</sup>
 </xref>, 
 <xref rid="rmv2161-bib-0038" ref-type="ref">
  <sup>38</sup>
 </xref>, 
 <xref rid="rmv2161-bib-0039" ref-type="ref">
  <sup>39</sup>
 </xref> The complexity of diverse disease severities, prolonged infectious periods, and shared clinical manifestations and pathogenesis have made their diagnosis, treatment, and resource allocation challenging, particularly in developing countries in Asia with high prevalence of dengue and other arboviruses.
</p>
